Local thermal ablative therapies for extracranial oligometastatic disease of non-small-cell lung cancer

被引:2
|
作者
Kong, Yongmei [1 ,2 ,3 ]
Xu, Hui [1 ,2 ,3 ]
Huang, Yahan [1 ,2 ,3 ]
Wei, Zhigang [1 ,2 ]
Ye, Xin [1 ,2 ]
机构
[1] Shandong First Med Univ, Affiliated Hosp 1, Dept Oncol, Jinan 250000, Shandong, Peoples R China
[2] Shandong Prov Qianfoshan Hosp, Shandong Lung Canc Inst, Shandong Key Lab Rheumat Dis & Translat Med, Jinan 250000, Shandong, Peoples R China
[3] Shandong First Med Univ, Jinan, Peoples R China
基金
中国国家自然科学基金;
关键词
extracranial; non-small cell lung cancer; oligometastatic diseases; thermal ablation; RADIOFREQUENCY ABLATION; MICROWAVE ABLATION; CLASSIFICATION; RADIOTHERAPY; METASTASIS; OUTCOMES; TUMOR; CHEMOTHERAPY; METAANALYSIS; MULTICENTER;
D O I
10.1111/ajco.13766
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Clinically, 40-50% of patients with NSCLC are found to have systemic metastasis at the initial diagnosis. Meanwhile, 30-75% of patients with lung cancer who have undergone radical surgical resection have local recurrence and distant metastases. However, not all distant metastases are multiple, and some are potentially curable. In this study, among the patients with NSCLC having distant organ metastasis, approximately 7% showed extrapulmonary solitary metastasis and remained in this relatively stable state for a long time. This form of metastasis is known as NSCLC oligometastases. This review describes the concept and classification of oligometastases, as well as the local treatment and prognosis of extracranial oligometastases.
引用
收藏
页码:3 / 8
页数:6
相关论文
共 50 条
  • [1] Local Ablative Therapies for Oligometastatic and Oligoprogressive Non-Small Cell Lung Cancer
    Jairam, Vikram
    Park, Henry S.
    Decker, Roy H.
    CANCER JOURNAL, 2020, 26 (02): : 129 - 136
  • [2] The role of local ablative therapy in oligometastatic non-small-cell lung cancer: hype or hope
    Bansal, Pranshu
    Rusthoven, Chad
    Boumber, Yanis
    Gan, Gregory N.
    FUTURE ONCOLOGY, 2016, 12 (23) : 2713 - 2727
  • [3] Local ablative radiotherapy for oligometastatic non-small cell lung cancer
    Suh, Yang-Gun
    Cho, Jaeho
    RADIATION ONCOLOGY JOURNAL, 2019, 37 (03): : 149 - 155
  • [4] Oligometastatic Disease in Non-Small-Cell Lung Cancer: An Update
    Chen, Yi-Hsing
    Ho, Ue-Cheung
    Kuo, Lu-Ting
    CANCERS, 2022, 14 (05)
  • [5] Surgery for oligometastatic disease in non-small-cell lung cancer
    Van Schil, Paul E.
    Hendriks, Jeroen M.
    Carp, Laurens
    Lauwers, Patrick R.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (12) : 1931 - 1938
  • [6] Oligometastatic Non-Small-Cell Lung Cancer
    Palma, David A.
    Videtic, Gregory M. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (02): : 223 - 226
  • [7] Local ablative non-surgical procedures for non-small-cell lung cancer
    Guckenberger, M.
    Flentje, M.
    ONKOLOGE, 2011, 17 (08): : 715 - 720
  • [8] Local Ablative Therapy Combined with Pembrolizumab in Oligometastatic Non-Small Cell Lung Cancer
    Lee, Hye In
    Choi, Eun Kyung
    Kim, Su Ssan
    Shin, Young Seob
    Park, Junhee
    Choi, Chang-Min
    Yoon, Shinkyo
    Kim, Hyeong Ryul
    Song, Si Yeol
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1634 - S1635
  • [9] Oligoprogression after Local Ablative Treatment for Oligometastatic Non-Small Cell Lung Cancer
    Steinmann, N.
    Werner, R. S.
    Opitz, I.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S589 - S589
  • [10] Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer
    Juan, Oscar
    Popat, Sanjay
    CLINICAL LUNG CANCER, 2017, 18 (06) : 595 - 606